Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 1602-1613, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urnovitz, H. B.
Right arrow Articles by Murphy, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urnovitz, H. B.
Right arrow Articles by Murphy, W. H.
Related Collections
Right arrow Clinical Immunology
Right arrow Oak Ridge Conference
(Clinical Chemistry. 1999;45:1602-1613.)
© 1999 American Association for Clinical Chemistry, Inc.

Articles

Urine Antibody Tests: New Insights into the Dynamics of HIV-1 Infection

Howard B. Urnovitz1,a, Jerrilyn C. Sturge1, Toby D. Gottfried1 and William H. Murphy2

1 Calypte Biomedical, Berkeley, CA 94710.

2 Department of Microbiology and Immunology, The University of Michigan School of Medicine, Ann Arbor, MI 48109-0620.
a Address correspondence to this author at: Calypte Biomedical, 1440 Fourth St., Berkeley, CA 94710. Fax 510-526-5381; e-mail hervdoc{at}aol.com

Background: Noninvasive methodologies provide alternatives to diagnostic blood tests and have high patient acceptance, increased safety, and reduced costs. Such tests may supplement or replace blood diagnostic assays currently in use.

Methods: Using a licensed urine-based test for antibody to HIV-1, we performed 25 991 HIV-1 urine antibody enzyme immunoassay (EIA) screening tests [confirmable by HIV-1 Western blot (WB)] on paired urine and blood specimens obtained from high- and low-risk HIV-1 subjects collected at six sites representative of the US population.

Results: Using HIV-1 urine EIA tests confirmed by urine Western blot, a compartmentalized immune response (urine positive/serum negative) occurred in 0.24% of a cohort of 11 896 subjects. In the same cohort, specimens that were urine negative/serum positive occurred in 0.17% of subjects. In a second study of 25 991 subjects that included 859 high-risk individuals, the false-positive urine EIA frequency (urine WB negative or indeterminate) was 1.3%. This false-positive frequency in the high-risk cohort was attributed, in part, to an IgA antibody response. We tabulated urine and serum indeterminate reactivities and examined their possible causes. Data are presented showing that antibodies from a seroindeterminate HIV-1vau group O subject were reactive in urine EIA and urine WB tests. An analysis of the HIV-1vau strain group O env nucleotide sequence disclosed a high frequency of homology with human chromosome 7q31, a fragile site implicated in many human malignancies.

Conclusions: These results demonstrate the utility of urine for alternative HIV-1 antibody testing and provide new insights into the pathogenesis of HIV-1 infection and into potential application of this approach in investigation of other microbial pathogens and toxic compounds.




The following articles in journals at HighWire Press have cited this article:


Home page
 CVIHome page
M. Guan
Frequency, Causes, and New Challenges of Indeterminate Results in Western Blot Confirmatory Testing for Antibodies to Human Immunodeficiency Virus
Clin. Vaccine Immunol., June 1, 2007; 14(6): 649 - 659.
[Full Text] [PDF]

Home page
 J. Virol.Home page
M. L. Santiago, M. Lukasik, S. Kamenya, Y. Li, F. Bibollet-Ruche, E. Bailes, M. N. Muller, M. Emery, D. A. Goldenberg, J. S. Lwanga, et al.
Foci of Endemic Simian Immunodeficiency Virus Infection in Wild-Living Eastern Chimpanzees (Pan troglodytes schweinfurthii)
J. Virol., July 1, 2003; 77(13): 7545 - 7562.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B. Ling, M. L. Santiago, S. Meleth, B. Gormus, H. M. McClure, C. Apetrei, B. H. Hahn, and P. A. Marx
Noninvasive Detection of New Simian Immunodeficiency Virus Lineages in Captive Sooty Mangabeys: Ability To Amplify Virion RNA from Fecal Samples Correlates with Viral Load in Plasma
J. Virol., February 1, 2003; 77(3): 2214 - 2226.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
W. M. R. Oelemann, C. M. Lowndes, G. C. Verissimo da Costa, M. G. Morgado, L. R. R. Castello-Branco, B. Grinsztejn, M. Alary, and F. I. Bastos
Diagnostic Detection of Human Immunodeficiency Virus Type 1 Antibodies in Urine: a Brazilian Study
J. Clin. Microbiol., March 1, 2002; 40(3): 881 - 885.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.